Original Article

You have full text access to this OnlineOpen article

A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia

  1. Mark A. Weiss M.D.1,
  2. Timothy B. Aliff M.D.1,‡,*,
  3. Martin S. Tallman M.D.2,
  4. Stanley R. Frankel M.D.3,†,
  5. Matt E. Kalaycio M.D.4,
  6. Peter G. Maslak M.D.1,
  7. Joseph G. Jurcic M.D.1,
  8. David A. Scheinberg M.D., Ph.D.1,
  9. Todd E. Roma B.S.1

Article first published online: 23 JUL 2002

DOI: 10.1002/cncr.10707

Issue

Cancer

Cancer

Volume 95, Issue 3, pages 581–587, 1 August 2002

Additional Information

How to Cite

Weiss, M. A., Aliff, T. B., Tallman, M. S., Frankel, S. R., Kalaycio, M. E., Maslak, P. G., Jurcic, J. G., Scheinberg, D. A. and Roma, T. E. (2002), A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia. Cancer, 95: 581–587. doi: 10.1002/cncr.10707

Author Information

  1. 1

    Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

  2. 2

    Northwestern University Medical School, Chicago, Illinois

  3. 3

    Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC

  4. 4

    Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio

  1. †

    Genta Incorporated, Two Connell Drive, Berkeley Heights, NJ 07922

  1. ‡

    Fax: (212) 772-8441

*Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021

Publication History

  1. Issue published online: 23 JUL 2002
  2. Article first published online: 23 JUL 2002
  3. Manuscript Accepted: 7 MAR 2002
  4. Manuscript Revised: 26 FEB 2002
  5. Manuscript Received: 3 DEC 2001

Funded by

  • Pharmacia and Upjohn
  • Amgen, Inc.
  • NIH. Grant Number: -5-T32-CA-09207-24

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (79K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sujata Narayanan, Paul J. Shami, Treatment of acute lymphoblastic leukemia in adults, Critical Reviews in Oncology/Hematology, 2012, 81, 1, 94

    CrossRef

  2. 2
    Jong Hyung Yoon, Jeong Ah Park, Eun Kyung Kim, Hyoung Jin Kang, Hee Young Shin, Hyo Seop Ahn, Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia, Journal of Korean Medical Science, 2009, 24, 2, 281

    CrossRef

  3. 3
    Paul Tardi, Sharon Johnstone, Natashia Harasym, Sherwin Xie, Troy Harasym, Natalia Zisman, Pierrot Harvie, David Bermudes, Lawrence Mayer, In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy, Leukemia Research, 2009, 33, 1, 129

    CrossRef

  4. 4
    Alessandra Tedeschi, Marco Montillo, Elena Strocchi, Anna Maria Cafro, Elisabetta Tresoldi, Liliana Intropido, Michele Nichelatti, Laura Marbello, Claudia Baratè, Carlo Maurizio Camaggi, Enrica Morra, High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study, Cancer Chemotherapy and Pharmacology, 2007, 59, 6, 771

    CrossRef

  5. 5
    Asha Johny, Kevin W. Song, Stephen H. Nantel, Julye C. Lavoie, Cynthia L. Toze, Donna E. Hogge, Donna L. Forrest, Heather J. Sutherland, Alan Le, Janet Y. Nitta, Michael J. Barnett, Clayton A. Smith, John D. Shepherd, Thomas J. Nevill, Early Stem Cell Transplantation for Refractory Acute Leukemia after Salvage Therapy with High-Dose Etoposide and Cyclophosphamide, Biology of Blood and Marrow Transplantation, 2006, 12, 4, 480

    CrossRef

  6. 6
    Anna Candoni, Angela Michelutti, Erica Simeone, Daniela Damiani, Michele Baccarani, Renato Fanin, Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins, European Journal of Haematology, 2006, 77, 4
    Direct Link:
  7. 7
    Eros Di Bona, Enrico Pogliani, Giuseppe Rossi, Teresa Lerede, Anna D'Emilio, Michele Vespignani, Francesco Rodeghiero, Tiziano Barbui, Renato Bassan, Transplant-finalized salvage of adult acute lymphoblastic leukemia: results of a mitoxantrone- and methotrexate-based regimen in 36 patients, Leukemia & Lymphoma, 2005, 46, 6, 879

    CrossRef

  8. 8
    Renato Bassan, Gemma Gatta, Carlo Tondini, Roel Willemze, Adult acute lymphoblastic leukaemia, Critical Reviews in Oncology/Hematology, 2004, 50, 3, 223

    CrossRef

  9. 9
    Merat Karbasian-Esfahani, Peter H. Wiernik, Yelena Novik, Elisabeth Paietta, Janice P. Dutcher, Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia, Cancer, 2004, 101, 6
    Direct Link:
  10. 10
    Mark R Litzow, The therapy of relapsed acute leukaemia in adults, Blood Reviews, 2004, 18, 1, 39

    CrossRef

  11. 11
    Current Awareness in Hematological Oncology, Hematological Oncology, 2003, 21, 1
    Direct Link:
View Full Article (HTML) Get PDF (79K)